ALLERGAN INC·4/A

Jan 18, 6:54 PM ET

ROSSO LOUIS T 4/A

4/A · ALLERGAN INC · Filed Jan 18, 2005

Insider Transaction Report

Form 4/AAmended
Period: 2004-11-30
Transactions
  • Award

    Phantom Stock Units

    2004-11-30$73.50/sh+27.21$2,00021,798.35 total
    Common Stock (0 underlying)
Footnotes (5)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Previous amount erroneously reported. Holdings subsequently reported on 1-5-05 should be adjusted accordingly.
  • [F4]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
  • [F5]Previous stock price erroneously reported.

Documents

1 file
  • 4
    ros335.xml